Cambridge Cognition Holdings PLC (AIM:COG) CEO Matthew Stork speaks to Proactive following the acquisition of virtual clinical trial firm eClinicalHealth.
The AIM-listed developer of digital brain health assessments said the purchase would expand its existing virtual clinical trial offering, with eCH providing the digital technology for three of the world's 10 largest pharmaceutical companies under its Clinpal brand.